Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug testing and analysis

Showing results (1091-1100 of 2,524) with videos related to

Pageof 253
Sort By:
Drug Testing and Analysis|August 16, 2016
Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedroneGavin McLaughlin, Noreen Morris, Pierce V Kavanagh, et al.
Drug Testing and Analysis|July 23, 2015
Estimates of tobacco use by wastewater analysis of anabasine and anatabineBen J Tscharke, Jason M White, Jacobus P Gerber
Drug Testing and Analysis|February 17, 2026
In Vitro Metabolism of 1-Benzoyl-Lysergic Acid Diethylamide (1Bz-LSD) and Identification of a Deethylated Metabolite (1Bz-LAE) Using a Synthesized Reference StandardYuki Azuma, Akiko Asada, Misa Tanaka, et al.
Drug Testing and Analysis|August 27, 2025
Biosynthesis and Identification of Clenbuterol Metabolites in Urine and In Vitro Microsome Incubation Samples Using UHPLC-Q-Exactive Orbitrap Mass Spectrometry: A Comparison Between Human and Bovine MetabolismAnuar Gómez-Tagle, Claudia Bressan, Rosa Ventura, et al.
Drug Testing and Analysis|July 1, 2020
Alternative markers for Methylnortestosterone misuse in human urinePanagiotis Sakellariou, Polyxeni Kiousi, Argyro G Fragkaki, et al.
Drug Testing and Analysis|April 17, 2023
Effects of new anti-doping measures on sports performance in elite female athletesEduard Bezuglov, Oleg Talibov, Artemii Lazarev, et al.
Drug Testing and Analysis|April 17, 2021
Re-evaluation of combined ((ES/EG)/(TS/TG)) ratio as a marker of testosterone intake in menJenny Schulze, Kim Pettersson-Bohlin, John-Olof Thörngren, et al.
Drug Testing and Analysis|April 17, 2021
Nontargeted detection of designer androgens: Underestimated role of in vitro bioassaysRachel A Lund, Elliot R Cooper, Hui Wang, et al.
Drug Testing and Analysis|May 29, 2015
Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MSMira Sundström, Anna Pelander, Kaarlo Simojoki, et al.
Drug Testing and Analysis|May 28, 2015
Structure elucidation of the designer drug N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-pyrazole-5-carboxamide and the relevance of predicted (13) C NMR shifts - a case studyUlrich Girreser, Peter Rösner, Andrej Vasilev
Pageof 253

Showing results (1091-1100 of 2,524) with videos related to

Sort By:
Pageof 253
Drug Testing and Analysis|August 16, 2016
Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedroneGavin McLaughlin, Noreen Morris, Pierce V Kavanagh, et al.
Drug Testing and Analysis|July 23, 2015
Estimates of tobacco use by wastewater analysis of anabasine and anatabineBen J Tscharke, Jason M White, Jacobus P Gerber
Drug Testing and Analysis|February 17, 2026
In Vitro Metabolism of 1-Benzoyl-Lysergic Acid Diethylamide (1Bz-LSD) and Identification of a Deethylated Metabolite (1Bz-LAE) Using a Synthesized Reference StandardYuki Azuma, Akiko Asada, Misa Tanaka, et al.
Drug Testing and Analysis|August 27, 2025
Biosynthesis and Identification of Clenbuterol Metabolites in Urine and In Vitro Microsome Incubation Samples Using UHPLC-Q-Exactive Orbitrap Mass Spectrometry: A Comparison Between Human and Bovine MetabolismAnuar Gómez-Tagle, Claudia Bressan, Rosa Ventura, et al.
Drug Testing and Analysis|July 1, 2020
Alternative markers for Methylnortestosterone misuse in human urinePanagiotis Sakellariou, Polyxeni Kiousi, Argyro G Fragkaki, et al.
Drug Testing and Analysis|April 17, 2023
Effects of new anti-doping measures on sports performance in elite female athletesEduard Bezuglov, Oleg Talibov, Artemii Lazarev, et al.
Drug Testing and Analysis|April 17, 2021
Re-evaluation of combined ((ES/EG)/(TS/TG)) ratio as a marker of testosterone intake in menJenny Schulze, Kim Pettersson-Bohlin, John-Olof Thörngren, et al.
Drug Testing and Analysis|April 17, 2021
Nontargeted detection of designer androgens: Underestimated role of in vitro bioassaysRachel A Lund, Elliot R Cooper, Hui Wang, et al.
Drug Testing and Analysis|May 29, 2015
Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MSMira Sundström, Anna Pelander, Kaarlo Simojoki, et al.
Drug Testing and Analysis|May 28, 2015
Structure elucidation of the designer drug N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-pyrazole-5-carboxamide and the relevance of predicted (13) C NMR shifts - a case studyUlrich Girreser, Peter Rösner, Andrej Vasilev
Pageof 253